Spots Global Cancer Trial Database for hypofractionated radiotherapy
Every month we try and update this database with for hypofractionated radiotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial) | NCT03816475 | Myxoid Liposarc... | Hypofractionate... | 18 Years - | Maria Sklodowska-Curie National Research Institute of Oncology | |
| Stereotactic Volumetric Radiotherapy in Prostate Cancer | NCT02423889 | Prostate Cancer | Radiotherapy | 18 Years - | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | |
| Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM) | NCT05453682 | Bladder Cancer | hypo-IMRT | 20 Years - | Samsung Medical Center | |
| Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer. | NCT05318274 | Ductal Breast C... Invasive Breast... Early-stage Bre... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... | Hypofractionate... | 18 Years - | Coordinación de Investigación en Salud, Mexico | |
| NSCLC Isotoxic Hypofractionated Chemoradiotherapy | NCT03606239 | Carcinoma, Non-... | isotoxic hypofr... | 18 Years - 75 Years | The Second Hospital of Hebei Medical University | |
| A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors | NCT02819843 | Melanoma Merkel Cell Car... Other Solid Tum... | TALIMOGENE LAHE... Hypofractionate... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Breast Cancer With Intraoperative Radiotherapy Followed by Hypofractionated External Beam Radiotherapy | NCT05498311 | Breast Cancer | Intraoperative ... Breast conserva... External Beam H... | 45 Years - | Institut Català d'Oncologia | |
| Accelerated Radiotherapy Outcomes in Women | NCT00156130 | Breast Cancer | Conventional ra... Accelarated rad... | - | Ontario Clinical Oncology Group (OCOG) | |
| Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment | NCT02812654 | Sarcoma, Soft T... | Doxorubicin Ifosfamide radiotherapy | 18 Years - 75 Years | AC Camargo Cancer Center | |
| Trial of Hypofractionated Radiation Therapy for Glioblastoma | NCT02206230 | Glioblastoma | Hypofractionate... Standard radiat... | 18 Years - 70 Years | AHS Cancer Control Alberta | |
| Fraction Dose Escalation of Hypo-fractionated Radiotherapy in LANSCLC | NCT04951063 | Locally Advance... | Hypofractionate... Concurrent chem... Consolidation i... | 18 Years - 75 Years | Sun Yat-sen University | |
| PRaG Regimens Rechallenge for Patients With Resistance to PD1/PD-L1 Inhibitors in Refractory Advanced Solid Tumors. | NCT05530200 | Metastatic Soli... | Hypofractionate... PD-L1 inhibitor GM-CSF IL-2 | 18 Years - | Second Affiliated Hospital of Soochow University | |
| Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall | NCT03651375 | Sarcoma Fibrosarcoma Leiomyosarcoma Liposarcoma Myosarcoma Histiocytic Sar... Synovial Sarcom... Lymphangiosarco... Malignant Perip... Myxofibrosarcom... Myxoid Liposarc... Undifferentiate... Pleomorphic Lip... Undifferentiate... Dedifferentiate... Pleomorphic Rha... Malignant Trito... | Sequential chem... Hypofractionate... | 18 Years - 100 Years | Maria Sklodowska-Curie National Research Institute of Oncology | |
| Safety and Efficacy Study of Dose-escalated Hypofractionated Radiotherapy For Prostate Cancer | NCT01146340 | Prostate Cancer | Hypofractionate... | 18 Years - | Sunnybrook Health Sciences Centre | |
| A Study of Erlotinib Plus Radiotherapy (RT) for Patients With Advanced or Inoperable Non-Small-Cell Lung Cancer | NCT00983307 | Carcinoma, Non-... | Erlotinib Hypofractionate... | 18 Years - | Thomas Jefferson University | |
| RapidPlan Models Establishment for Node-Positive Breast Cancer Treated With Hypofractionation Using Edge/Truebeam | NCT05486936 | Breast Cancer | hypofractionate... | 18 Years - 75 Years | Ruijin Hospital | |
| Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma | NCT05439278 | Glioblastoma | Hypofractionate... Conventional ra... Temozolomide | 70 Years - | Seoul National University Boramae Hospital | |
| Chemotherapy and Pelvic Hypofractionated Radiation Followed by Surgery Cervical Cancer | NCT03750539 | Cervix Cancer | Standard radiot... hypofractionate... Radical hystere... | 18 Years - 80 Years | National Institute of Cancerología | |
| Stereotactic Volumetric Radiotherapy in Prostate Cancer | NCT02423889 | Prostate Cancer | Radiotherapy | 18 Years - | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | |
| Fraction Dose Escalation of Hypo-fractionated Radiotherapy in LANSCLC | NCT04951063 | Locally Advance... | Hypofractionate... Concurrent chem... Consolidation i... | 18 Years - 75 Years | Sun Yat-sen University | |
| Hypofractionated Radiotherapy Versus Stereotactic Irradiation With Hyaluronic Acid | NCT02361515 | Prostatic Adeno... | Moderate hypofr... Stereotactic ra... | 18 Years - 80 Years | Hospices Civils de Lyon | |
| Chemotherapy and Pelvic Hypofractionated Radiation Followed by Brachytherapy for Cervical Cancer | NCT04070976 | Cervical Cancer | Hypofractionate... Standard therap... | 18 Years - | National Institute of Cancerología | |
| Breast Cancer With Intraoperative Radiotherapy Followed by Hypofractionated External Beam Radiotherapy | NCT05498311 | Breast Cancer | Intraoperative ... Breast conserva... External Beam H... | 45 Years - | Institut Català d'Oncologia | |
| Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI Therapy | NCT02787447 | Lung Adenocarci... | TKI Thoracic Hypofr... Thymosin Alpha ... | 18 Years - 75 Years | First People's Hospital of Hangzhou | |
| NSCLC Isotoxic Hypofractionated Chemoradiotherapy | NCT03606239 | Carcinoma, Non-... | isotoxic hypofr... | 18 Years - 75 Years | The Second Hospital of Hebei Medical University | |
| Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor | NCT03663764 | Thymoma and Thy... | Thymosin a1 hypofractionate... concurrent chem... | 18 Years - 70 Years | Sun Yat-sen University | |
| Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors | NCT01936961 | Metastatic Non-... Metastatic Colo... Metastatic Trip... | CTLA-4 Antibody Hypofractionate... | 18 Years - | Western Regional Medical Center | |
| Hyaluronic Acid for Hypofractionated Prostate Radiotherapy | NCT02165020 | Prostate Cancer | Hyaluronic acid... | 18 Years - 80 Years | Hospices Civils de Lyon | |
| Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial) | NCT05191940 | Pancreas Cancer | Particle-therap... Blood sampling Magnetic resona... Computertomogra... 18-F-FluorDesox... | 18 Years - | EBG MedAustron GmbH | |
| Prostate Cancer Stereotactic Radiotherapy | NCT02319239 | Prostate Neopla... Toxicity Due to... | Fractionation hypofractionate... stereotactic fr... | 30 Years - | Tampere University Hospital | |
| Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment | NCT02812654 | Sarcoma, Soft T... | Doxorubicin Ifosfamide radiotherapy | 18 Years - 75 Years | AC Camargo Cancer Center | |
| Hypofractionated Radiotherapy Followed by Hypo-boost for Local Advanced NSCLC | NCT03900117 | Non-small Cell ... | split-course ra... concurrent chem... | 18 Years - 75 Years | Sun Yat-sen University | |
| Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma | NCT05224934 | Soft Tissue Sar... Retroperitoneal... Radiotherapy Si... Ultra-hypofract... Stereotactic Ab... | ultra-hypofract... | 18 Years - | ChineseAMS | |
| Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLC | NCT02947113 | Non-Small Cell ... | Cisplatin hypofractionate... Pemetrexed Etoposide | 18 Years - | The Netherlands Cancer Institute | |
| A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy | NCT02788058 | Lung Adenocarci... EGFR Positive N... | EGFR-TKI Thoracic Hypofr... | 18 Years - 75 Years | First People's Hospital of Hangzhou | |
| A Study Involving Neoadjuvant Chemoradiotherapy With Hypofractionated Radiotherapy in Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma | NCT05370144 | Esophageal Canc... | Hypofractionate... | 18 Years - 75 Years | AHS Cancer Control Alberta | |
| Chemotherapy and Pelvic Hypofractionated Radiation Followed by Surgery Cervical Cancer | NCT03750539 | Cervix Cancer | Standard radiot... hypofractionate... Radical hystere... | 18 Years - 80 Years | National Institute of Cancerología | |
| Hypofractionated Radiotherapy and Concurrent Cisplatin for Head and Neck Cancer | NCT03194061 | Radiotherapy; C... | Hypofractionate... Weekly cisplati... | 18 Years - | Barretos Cancer Hospital | |
| External Hypofractionated Radiotherapy With Simultaneous Integrated Boost in Early Breast Cancer Patients | NCT06224244 | Breast Neoplasm... Breast Cancer | Ten-fraction hy... Ten-fraction hy... | 18 Years - | Regina Elena Cancer Institute | |
| Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer | NCT00129025 | Prostate Cancer | Hypofractionate... | - | AHS Cancer Control Alberta | |
| Hypofractionated Radiotherapy Combined With PD-1 Inhibitor Sequential GM-CSF and IL-2 for the Treatment of Advanced Refractory Solid Tumors (PRaG2.0) | NCT04892498 | Advanced Refrac... | Hypofractionate... PD-1 inhibitor GM-CSF IL-2 | 18 Years - | Second Affiliated Hospital of Soochow University | |
| NSCLC Isotoxic Hypofractionated Chemoradiotherapy | NCT03606239 | Carcinoma, Non-... | isotoxic hypofr... | 18 Years - 75 Years | The Second Hospital of Hebei Medical University | |
| Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer | NCT00129025 | Prostate Cancer | Hypofractionate... | - | AHS Cancer Control Alberta | |
| Moderate Hypofractionated Radiotherapy for Lung Cancer | NCT03833193 | Lung Cancer | Hypofractionate... | 18 Years - | North China Petroleum Bureau General Hospital | |
| Hypofractionated Radiotherapy Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children | NCT01635140 | Pediatric Brain... | Hypofractionate... Conventional ar... | 3 Years - 18 Years | Children's Cancer Hospital Egypt 57357 | |
| Trial Comparing Radical Radiotherapy to Prostate Only VS Prostate And Pelvic Lymph Nodes in Intermediate And High Risk Prostate Cancer | NCT05285319 | Prostate Cancer | Prostate Only R... Prostate and Pe... | - | Cairo University | |
| Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLC | NCT02947113 | Non-Small Cell ... | Cisplatin hypofractionate... Pemetrexed Etoposide | 18 Years - | The Netherlands Cancer Institute | |
| Hypofractionated Versus Standard Fractionated Whole Breast Irradiation to Node-negative Breast Cancer Patients | NCT00909818 | Breast Cancer Carcinoma in Si... | standard fracti... hypofractionate... | 41 Years - | Danish Breast Cancer Cooperative Group | |
| A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy | NCT02788058 | Lung Adenocarci... EGFR Positive N... | EGFR-TKI Thoracic Hypofr... | 18 Years - 75 Years | First People's Hospital of Hangzhou | |
| A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70 | NCT01985087 | Glioblastoma | Hypofractionate... Temozolomide | 70 Years - | University of Louisville | |
| To Explore the Efficacy of Hypofractionated Radiotherapy Followed by AG Regimen Chemotherapy Plus Camrelizumab Immunotherapy as Neoadjuvant Therapy for Locally Advanced Pancreatic Cancer | NCT06435260 | Pancreatic Canc... | Camrelizumab+ch... hypofractionate... | 18 Years - 75 Years | Hebei Medical University Fourth Hospital | |
| Prospective Trial of Two Hypofractionated Radiotherapy Regimens Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children | NCT01878266 | Pediatric Brain... | Hypofractionate... Hypofractionate... Conventional Ar... | 2 Years - 18 Years | Children's Cancer Hospital Egypt 57357 | |
| A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC | NCT02463994 | Non-small Cell ... | MPDL3280A Hypofractionate... | 18 Years - | University of Michigan Rogel Cancer Center | |
| Hypofractionated Palliative Radiotherapy in Patients With Advanced Non-operable Rectal Cancer | NCT03853733 | Rectal Cancer | rectal cancer r... | 18 Years - | Consorci Sanitari de Terrassa | |
| Hypofractionated Radiotherapy and Concurrent Cisplatin for Head and Neck Cancer | NCT03194061 | Radiotherapy; C... | Hypofractionate... Weekly cisplati... | 18 Years - | Barretos Cancer Hospital | |
| A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLC | NCT04543890 | Small Cell Lung... | Hyperfractionat... Hypofractionate... Etoposide Cisplatin | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
| Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer. | NCT05318274 | Ductal Breast C... Invasive Breast... Early-stage Bre... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... | Hypofractionate... | 18 Years - | Coordinación de Investigación en Salud, Mexico | |
| Safety and Efficacy Study of Dose-escalated Hypofractionated Radiotherapy For Prostate Cancer | NCT01146340 | Prostate Cancer | Hypofractionate... | 18 Years - | Sunnybrook Health Sciences Centre | |
| Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial) | NCT05191940 | Pancreas Cancer | Particle-therap... Blood sampling Magnetic resona... Computertomogra... 18-F-FluorDesox... | 18 Years - | EBG MedAustron GmbH | |
| Hypofractionated Radiotherapy Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children | NCT01635140 | Pediatric Brain... | Hypofractionate... Conventional ar... | 3 Years - 18 Years | Children's Cancer Hospital Egypt 57357 | |
| Moderate Hypofractionated Radiotherapy for Lung Cancer | NCT03833193 | Lung Cancer | Hypofractionate... | 18 Years - | North China Petroleum Bureau General Hospital | |
| A Study Involving Neoadjuvant Chemoradiotherapy With Hypofractionated Radiotherapy in Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma | NCT05370144 | Esophageal Canc... | Hypofractionate... | 18 Years - 75 Years | AHS Cancer Control Alberta | |
| Hypofractionated Radiotherapy for Soft Tissue Sarcomas | NCT03972930 | Soft Tissue Sar... | Hypofractionate... | 18 Years - | University of Wisconsin, Madison | |
| A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors | NCT02819843 | Melanoma Merkel Cell Car... Other Solid Tum... | TALIMOGENE LAHE... Hypofractionate... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas | NCT04506008 | Soft Tissue Sar... | Ultra-Hypo-frac... Resection Questionnaire A... Moderately-Hypo... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Trial of Hypofractionated Radiation Therapy for Glioblastoma | NCT02206230 | Glioblastoma | Hypofractionate... Standard radiat... | 18 Years - 70 Years | AHS Cancer Control Alberta | |
| HFSRT With Concurrent TMZ for Large BMs | NCT03778541 | Brain Metastase... Chemotherapy Radiotherapy | Temozolomide hypofractionate... | 18 Years - 75 Years | ChineseAMS | |
| Hypofractionated Palliative Radiotherapy in Patients With Advanced Non-operable Rectal Cancer | NCT03853733 | Rectal Cancer | rectal cancer r... | 18 Years - | Consorci Sanitari de Terrassa | |
| Trial of Hypofractionated Radiation Therapy for Glioblastoma | NCT02206230 | Glioblastoma | Hypofractionate... Standard radiat... | 18 Years - 70 Years | AHS Cancer Control Alberta | |
| Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial) | NCT05191940 | Pancreas Cancer | Particle-therap... Blood sampling Magnetic resona... Computertomogra... 18-F-FluorDesox... | 18 Years - | EBG MedAustron GmbH | |
| Post Mastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer | NCT03319069 | Breast Cancer | Hypofractionate... Conventional fr... | 18 Years - 75 Years | Assiut University | |
| Prostate Cancer Stereotactic Radiotherapy | NCT02319239 | Prostate Neopla... Toxicity Due to... | Fractionation hypofractionate... stereotactic fr... | 30 Years - | Tampere University Hospital | |
| External Hypofractionated Radiotherapy With Simultaneous Integrated Boost in Early Breast Cancer Patients | NCT06224244 | Breast Neoplasm... Breast Cancer | Ten-fraction hy... Ten-fraction hy... | 18 Years - | Regina Elena Cancer Institute | |
| Short-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant Lesion | NCT01913717 | Adenocarcinoma ... | External beam r... | 18 Years - | European Institute of Oncology | |
| Hypofractionated Radiation Therapy in Patients With Breast Cancer | NCT04075058 | Breast Cancer | Hypofractionate... | 18 Years - 80 Years | PGIMER | |
| Post Mastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer | NCT03319069 | Breast Cancer | Hypofractionate... Conventional fr... | 18 Years - 75 Years | Assiut University | |
| Fraction Dose Escalation of Hypo-fractionated Radiotherapy in LANSCLC | NCT04951063 | Locally Advance... | Hypofractionate... Concurrent chem... Consolidation i... | 18 Years - 75 Years | Sun Yat-sen University | |
| Hypofractionated Radiation Therapy in Patients With Breast Cancer | NCT04075058 | Breast Cancer | Hypofractionate... | 18 Years - 80 Years | PGIMER | |
| RapidPlan Models Establishment for Node-Positive Breast Cancer Treated With Hypofractionation Using Edge/Truebeam | NCT05486936 | Breast Cancer | hypofractionate... | 18 Years - 75 Years | Ruijin Hospital | |
| BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy | NCT04454528 | Breast Cancer | Hypofractionate... Pembrolizumab i... Blood and tissu... | 18 Years - | Abramson Cancer Center at Penn Medicine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
